HyOrc Corporation cash flow statement HYOR

In fiscal 2025, which ended Dec 31, 2025, HyOrc Corporation used $336,057 of cash from operations.

USD in millions, except per-share amounts and ratios. The percent under a figure is the change from the year before.

Line
FY 2026
Jun 30, 2026
FY 2025
Dec 31, 2025
FY 2016
Dec 31, 2016
FY 2015
Dec 31, 2015
FY 2014
Dec 31, 2014
FY 2013
Dec 31, 2013
FY 2012
Dec 31, 2012
FY 2011
Dec 31, 2011
Operating
Depreciation and amortization
—
0
—
—
—
—
—
—
Operating cash flow
—
-0
-0
+93.6%
-0
-127.3%
-0
+25.6%
-0
+38.5%
-0
-1956.0%
0
Investing
Investing cash flow
—
0
—
—
—
—
—
—
Financing
Debt repaid
—
—
—
—
0
-78.4%
—
0
+122171.4%
0
Short-term debt repaid
—
—
—
—
0
-86.3%
0
—
—
Financing cash flow
—
0
0
-93.8%
0
+132.2%
0
-29.6%
0
-34.4%
0
+2505057.1%
-0
Change in cash
Net change in cash
—
-0
—
—
—
—
—
—
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and ratios. Capital expenditures, debt repaid, dividends, and buybacks are positive amounts. Investing and financing cash flow keep the filing sign, so an outflow is negative. Free cash flow is operating cash flow minus capital expenditures. The first column is the trailing twelve months through the latest quarter. Returned to shareholders is dividends plus buybacks. Free cash flow margin, capital expenditures, and stock-based compensation are divided by revenue. Cash conversion is operating cash flow divided by net income. More on our methodology.

Company profile

Industry
Services-Engineering Services (SIC 8711)
Listed as
HYOR (OTC)
Fiscal year ends
December 31
Incorporated in
WY
Headquarters
San Diego, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1070789
Former names
ASIA PROPERTIES INC (until May 26, 2021)

Other Services-Engineering Services companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.